Article · 2 Jun 2026
Conference abstract
Perlecan domain V promotes neuronal regeneration of stroked brain tissue
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Stroke is a significant world-wide cause of mortality and profound morbidity. Despite this sobering fact, little progress has been made in developing new therapies. Indeed, promising neuroprotective therapies have consistently failed to translate from animals to human patients. With this in mind, we hypothesized that better stroke therapies might be identified from a better understanding of the brain?s self-repairing stroke response. To this end, we have recently demonstrated that perlecan domain V (DV), a proteolytic fragment of the vascular basement membrane, is persistently generated after stroke and when administered via intraperitoneal injection 24 hours post-stroke is neuroprotective, enhances angiogenic brain repair, and inhibits chronic glial scar formation (a potential barrier to brain repair). Protection was observed in two distinct models of transient focal ischemia in mice and rats. DV treatment resulted in rapid functional recovery to pre-stroke levels in two days. We now investigated whether DV could also be therapeutic in a permanent focal ischemia model in both young and aged (an important clinical factor) as mice and whether it might enhance neurorepair. We now report that DV treatment in a motor cortex photothrombotic stroke model was also neuroprotective in both young and aged mice. Furthermore, these animals had significantly improved post-stroke motor function. Additionally, DV enhanced several aspects of post-stroke neuronal regeneration including neurogenesis, migration, and neuronal repopulation in the peri-infarct region and ischemic core. Collectively, these results suggest that DV may be a promising neuroregenerative stroke therapy.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Stem Cell Research & Therapy.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Stem Cell Research & Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Gregory Bix”
